SEP 18, 2017 12:02 PM PDT

Born with a Heart Defect: Twenty Years Later

WRITTEN BY: Kara Marker

A congenital heart defect that used to be a death sentence is now treatable thanks to an approach based on “Fontan circulation.” But as people who received this procedure as newborns grow older, researchers are seeing more instances where additional procedures are necessary to sustain the health of the heart.

A 6-month-old boy was admitted to the Camp Nathan Smith Medical Aid Clinic for complications related to a rare congenital heart defect. He is waiting to receive a life-saving cardiothoracic surgery at the Children's Hospital in Kabul.

Image credit: Spc. Breanne Pye

 

Single-ventricle disease is used to describe a variety of congenital heart defects that have one thing in common: one of the two ventricles is not functioning to its full potential. More than half of the babies that survive the three stages of procedures required to resolve single-ventricle diseases will require another heart procedure within 20 years, a new study from the Children’s Hospital of Philadelphia (CHOP) reports.

Depending on which ventricle is dysfunctional, single-ventricle disease is treated with a series of procedures designed to ultimately reach Fontan circulation: doctors empower the fully-functioning side of the heart to pick up the slack from the other side. The fully-functioning side completes the more difficult job of pumping oxygenated blood from the lungs to the rest of the body, and the blood returning from the body travels to the lungs “by direct blood vessel connections” rather than by the help of a ventricle as a pump.

The procedures begin within the first week of a baby’s life. The Fontan operation is done when the baby is between 18 months and two years old. It is the third and final stage of the repair and is done to make sure deoxygenated blood coming from the body tissues stops by the lungs before going to the heart.

"Unfortunately, for many patients, the Fontan is not the final intervention," explained study leader Andrew Glatz, MD.

While the Fontan operation gives babies with single-ventricle heart defects the best chance of living a normal life, it cannot provide normal blood circulation - it cannot make the defect obsolete. Additionally, there is a long-lasting risk of complications that are not yet fully understood by scientists.

The new study from CHOP was a retrospective review of 773 patients who had the Fontan operation at CHOP between 1992 and 2009. Researchers looked at re-intervention rates; how many babies who underwent the Fontan procedure grew up to require an additional procedure?

Results showed that 65 percent of the patients in the review had to have a re-intervention procedure within 20 years of their Fontan operation. Catheter-based procedures were the most common, mostly to “close unwanted openings or to widen narrowed blood vessels.” For those who underwent an operation, usually it was to “place or revise” a pacemaker.

“Many patients require further interventions after the Fontan to continue to try to optimize the circulation as best as possible,” Glatz explained. “It's important for families and doctors to understand this, so expectations are clear.”

The present study was published in the journal Circulation: Cardiovascular Interventions.

Sources: C.S. Mott Children’s Hospital, Cincinnati Children’s Hospital, Children’s Hospital of Philadelphia

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 23, 2019
Cardiology
JUL 23, 2019
Shocking Numbers Of People Self-Prescribing Daily Aspirin
Up until recently, people who were concerned about the possibility of suffering a cardiac event were often advised to take low-dose aspirin daily. Because ...
AUG 20, 2019
Cell & Molecular Biology
AUG 20, 2019
Discovery of Bone Bits in Blood may Help Explain Vascular Calcification
As we age, calcium can build up in various tissues in the body, and cause them to harden in a process called calcification....
SEP 18, 2019
Cardiology
SEP 18, 2019
Clear, Flexible Vital Sign Wearable Monitors
Wearable health monitors are gaining in popularity, both for fitness tracking and for gathering more targeted health data relating to heart disease and oth...
OCT 09, 2019
Drug Discovery & Development
OCT 09, 2019
Drug Increases Survival Rates for Heart Failure Patients
Scientists have demonstrated in preclinical studies that a drug called ‘Aliskiren’ works by inhibiting the activity of an enzyme involved in bl...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Experimental Cholesterol-Lowering Drug
A recent study shows that patients who take a maximum dose of statin drugs in addition to a twice-yearly injection of the experimental cholesterol-lowering...
DEC 19, 2019
Health & Medicine
DEC 19, 2019
Obesity on the rise in the United States
Even with a decade full of diet trends and superfoods, obesity rates in the United States continue to climb. According to a study published this week by 20...
Loading Comments...